Cerebral Therapeutics offers a new approach to managing neurological diseases by means of delivering precisely calibrated dosing to targeted sites within the brain.

Cerebral Therapeutics is focused on improving outcomes for patients with refractory epilepsy by targeting areas in the brain responsible for seizure generation and propagation.

Future Cerebral Therapeutic treatment areas include: obesity, Alzheimer’s disease, Parkinson’s disease, anxiety disorder and brain cancer.